The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR 2018) investigate joint replacement procedures in rheumatoid arthritis (RA) patients. The first study demonstrates that joint replacement procedures have significantly reduced in RA patients in the past decade and the second investigates the impact of biologic therapies on this change […]Continue Reading ...
July 20, 2018 With increased use of antibiotics worldwide linked to growing antibiotic resistance, a world-first study co-authored by a QUT researcher has highlighted the growing impact of non-prescription supply of antibiotics in community pharmacies, and the urgent need for better enforcement of laws. Global access to antibiotics without prescription in community pharmacies: a systematic […]Continue Reading ...
July 16, 2018 — Pfizer Inc. (NYSE:PFE) and Spark Therapeutics (NASDAQ:ONCE) announced today that Pfizer initiated a Phase 3 open-label, multi-center, lead-in study (NCT03587116) to evaluate the efficacy and safety of current factor IX prophylaxis replacement therapy in the usual care setting. The factor IX prophylaxis efficacy data obtained in the lead-in study will serve […]Continue Reading ...
July 18, 2018 A study led by Dr Mark Ashworth, Dr Maria Kordowicz and Professor Judith Green, School of Population Health & Environmental Sciences, reveals the complex reasons that patients develop multiple, long-term conditions in urban areas. Long-term conditions like coronary heart disease, diabetes and COPD are normally defined as having no cure but can […]Continue Reading ...
July 20, 2018 Multiple Sclerosis is an autoimmune disease that attacks and destroys a structure known as the “myelin sheath”, whose integrity is indispensable for the brain and spinal cord to function properly. Current treatment of Multiple Sclerosis is based on modulating the activity of the immune system or preventing its cells from accessing the […]Continue Reading ...
FDA Approves Krintafel (tafenoquine) for the Radical Cure of Plasmodium vivax Malaria London UK; Philadelphia US; Geneva, Switzerland – July 20, 2018 — GSK and Medicines for Malaria Venture (MMV) today announced that the United States Food and Drug Administration (FDA) has approved, under Priority Review, single-dose Krintafel (tafenoquine) for the radical cure (prevention of […]Continue Reading ...
July 18, 2018 Even in areas with moderate-to-high levels of traffic pollution, regular physical activity reduced the risk of first and recurrent heart attack, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association. “While exercise is known to reduce cardiovascular disease risk; […]Continue Reading ...
July 20, 2018 Researchers at Karolinska Institutet in Sweden report that sleep disturbances in midlife or in late life are associated with a higher risk for developing dementia in old age. The results are published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. The results show that in midlife, when participants were in […]Continue Reading ...
July 20, 2018 University of Kentucky health communication researcher Don Helme is partnering with the Kentucky Attorney General’s office to gauge public opinion on a new drug deactivation pouch, part of a larger effort to develop solutions to the state’s opioid epidemic. Last September Helme, an associate professor in the Department of Communication in the […]Continue Reading ...
Pictured is the control (upper left) in the mouse model of AD with varying levels of the deleted gene (other three panels). Note that Aβ; plaques (green) were fewer as the percent of the deletion (ΔUTR) increased. Scale bar: 1 mm. Credit: RIKEN National Science Institute Researchers at the RIKEN Center for Brain Science have […]Continue Reading ...
July 20, 2018 People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from Yale Cancer Center and the Cancer Outcomes, Public Policy and Effectiveness Research Center (COPPER) at Yale School […]Continue Reading ...
July 20, 2018 Recurrent injury rates were six times higher in girls’ soccer and nearly three times higher in girls’ basketball in schools without athletic trainers Availability of a full-time certified athletic trainer in high school reduces overall and recurrent injury rates in girls who play on the soccer or basketball team, according to a […]Continue Reading ...
The chemical structures and brain PET images of the novel 18F-labeled SV2A PET tracers, 18F-SDM-7, 18F-SDM-8, and the lead tracer 11C-UCB-J in nonhuman primates. Credit: Z Cai and S Li et al., Yale University, New Haven, Conn. New nuclear medicine tracers could help medical researchers find a cure for Alzheimer’s and other neurodegenerative diseases. The […]Continue Reading ...
By Sally Robertson, BScJuly 19, 2018 Scientists have made an important discovery about the role of a protein called PRMT5 in the production of myelin – the substance that forms a protective sheath around the axons of nerve cells. Image Credit: Jubal Harshaw / Shutterstock As well as providing new insights into the role of […]Continue Reading ...
July 20, 2018 Scientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionize treatment for age-related macular degeneration (AMD). AMD is the leading cause of blindness in the developed world. Its prevalence is increasing dramatically as the population ages and it is estimated that, by 2020, there […]Continue Reading ...
- Frequency of joint replacements halved in rheumatoid arthritis patients between 1997-2010
- QUT researcher highlights growing impact of non-prescription antibiotics supply in pharmacies
- UK health communication researcher seeks solutions for disposing leftover medicine
- Pfizer Initiates Pivotal Phase 3 Program for Investigational Hemophilia B Gene Therapy Fidanacogene Elaparvovec
- Mutation discovered to protect against Alzheimer’s disease in mice
- Researchers reveal how patients in urban areas develop multiple, long-term conditions
- Replacing conventional cancer treatment with complementary therapy linked to increased risk of death
- Study uncovers molecular key for delaying progression of multiple sclerosis
- Availability of athletic trainer in high school reduces injury rates in girls’ sports, shows study
- FDA Approves Krintafel (tafenoquine) for the Radical Cure of Plasmodium vivax Malaria
- Novel nuclear medicine probe will help assess new drugs for neurodegenerative diseases
- Physical activity even during exposure to air pollution can reduce risk of heart attack
- Scientists discover protein regulator of myelin production
- Sleep disturbances associated with higher dementia risk
- Scientists move one step further in developing eye drops to treat age-related macular degeneration
- Five-Year Stroke Rates Lower After PCI Versus CABG
- Alopecia areata – Genetics Home Reference
- Study identifies overdose risk factors in youth with substance use disorders
- Drug in clinical trials for Parkinson’s disease offers hope for treating heart failure
- Coupling free malaria tests with diagnosis-dependent vouchers can improve rational use of ACTs